Cellarity Stock

www.cellarity.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $277MM

Cellarity is a biotech company focused on designing medicines against the cell as opposed to a single molecular target by leveraging a unique combination of expertise across system and network biology, high-resolution data, and machine learning to unlock treatments in a large number of therapeutic areas.

Register for Details

For more details on financing and valuation for Cellarity, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Cellarity.

Register Today

Cellarity investors also invested in these private companies

Team

Management Team

Fabrice Chouraqui
Chief Executive Officer
Anna O’Driscoll
Chief People Officer
Chad Nusbaum
Chief Technology Officer
Laurens Kruidenier
Chief Scientific Officer

Board Members

Stephen Berenson
Flagship Pioneering
Avak Kahvejian
Flagship Pioneering
Jim Collins
Co-Founder
Carl P. Decicco
Foghorn Therapeutics
Marcello Damiani
Moderna Therapeutics
Ian Estepan
Serepta Therapeutics
Sandra Horning
Independent Advisor

Other companies like Cellarity in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B

News Highlights

Cellarity’s $121M Raise Signals A Promising Drug Discovery Strategy
Biotech startup Cellarity has raised $121 million in Series C funding, the company said Tuesday.
Updated on: Sep 30, 2023